Abstract
ObjectiveTo explore the mechanism of steroidogenic acute regulatory (StAR)-related lipid transfer domain containing 3 (STARD3) in breast cancer (BC). MethodsWe analysed the differential mRNA expressions of BC using ER+and ER-BC expression profiles from the cancer genome atlas (TCGA). Expression and correlation between salient genes was visualized using microarray volcano plots and a protein–protein interaction (PPI) network map. Survival analyses were performed to identify the potential for STARD3 to serve as a prognostic biomarker. The expression of STARD3 was examined by immunohistochemistry (IHC). The effects of STARD3 on apoptosis and proliferation of BC (MCF-7) cell line were deduced by flow cytometry, CCK8, and western blot (WB). ResultsSTARD3 was the most differentially expressed gene (DEG). Patients in the STARD3 high expression group had significantly lower survival than those in the low expression group. The expression of STARD3 was significantly higher in BC tissues than controls. Inhibiting STARD3 expression significantly increased apoptosis, decreased proliferation, activated PI3K/AKT/mTOR pathway ConclusionInhibiting the expression of STARD3 induced apoptosis via the inactivation of PI3K/AKT/mTOR pathway on BC inhibits tumour growth, which can be an effective therapeutic strategy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
